SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $5,684,000 | +8.8% | 21,842,662 | +0.3% | 6.41% | -11.1% |
Q1 2016 | $5,225,000 | -31.8% | 21,771,847 | +0.1% | 7.21% | -77.6% |
Q4 2015 | $7,659,000 | -88.1% | 21,758,894 | -41.4% | 32.13% | -63.1% |
Q3 2015 | $64,599,000 | -21.9% | 37,126,140 | +0.0% | 87.13% | -0.5% |
Q2 2015 | $82,762,000 | +15.1% | 37,113,186 | +0.1% | 87.59% | +2.1% |
Q1 2015 | $71,893,000 | -10.2% | 37,058,136 | +22.7% | 85.78% | -6.8% |
Q4 2014 | $80,025,000 | -12.0% | 30,197,945 | +0.0% | 92.06% | -1.6% |
Q3 2014 | $90,887,000 | -25.7% | 30,194,898 | +1.0% | 93.55% | -0.7% |
Q2 2014 | $122,258,000 | -1.0% | 29,891,849 | +4.4% | 94.25% | +0.0% |
Q1 2014 | $123,436,000 | -17.7% | 28,639,349 | -0.0% | 94.21% | -1.1% |
Q4 2013 | $150,057,000 | +0.6% | 28,641,849 | +21.2% | 95.29% | -4.6% |
Q3 2013 | $149,133,000 | +26.5% | 23,634,349 | +0.0% | 99.87% | +0.1% |
Q2 2013 | $117,923,000 | -33.2% | 23,631,849 | +15.1% | 99.78% | +0.0% |
Q1 2013 | $176,554,000 | -4.6% | 20,529,561 | +0.0% | 99.77% | +25.4% |
Q4 2012 | $185,156,000 | – | 20,527,277 | – | 79.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 37,061,186 | $82,646,000 | 87.47% |
Geller Advisors LLC | 187,323 | $418,000 | 0.24% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 430,749 | $961,000 | 0.22% |
Verity Asset Management, Inc. | 81,694 | $182,000 | 0.16% |
CAXTON CORP | 52,000 | $116,000 | 0.12% |
Catalyst Capital Advisors LLC | 400,000 | $892,000 | 0.10% |
Cutler Capital Management, LLC | 72,500 | $161,000 | 0.07% |
STONERIDGE INVESTMENT PARTNERS LLC | 239,202 | $533,000 | 0.07% |
SECOR Capital Advisors, LP | 35,087 | $78,000 | 0.03% |
Roundview Capital LLC | 29,100 | $65,000 | 0.02% |